On the Record · Smith & Nephew
Smith & Nephew acquisitions, on the record
The businesses Smith & Nephew bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
CartiHeal (2009) Ltd (CartiHeal)Word for word“We always look for great investment opportunities to add to our portfolio while providing differentiation for our customers such as the acquisition of CartiHeal (2009) Ltd (CartiHeal), the developer of CARTIHEAL◊ AGILI-C◊ that is a novel sports medicine technology for cartilage regeneration in the knee, which was announced on 22 November 2023.” 20-F for 2023 | agreed acquisition | 22 November 2023 | — |
CartiHealWord for word“Smith+Nephew paid $180 million on completion, with up to a further $150 million contingent on future financial performance.” 20-F for 2023 | acquisition | — | $180 million on completion, with up to a further $150 million contingent on future financial performance |
Engage SurgicalWord for word“We acquired this business in 2022 for a maximum consideration of $135 million payable in cash.” 20-F for 2023 | acquisition | in 2022 | maximum consideration of $135 million payable in cash |
Integrity Orthopaedics, IncWord for word“On 21 January 2026, we completed the acquisition of Integrity Orthopaedics, Inc, a US-based early stage commercial developer of Tendon Seam™, an innovative rotator cuff repair (RCR) system designed to significantly reduce re-tear rates and improve patient outcomes.” 20-F for 2025 | acquisition | On 21 January 2026 | — |
Read from Smith & Nephew’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-03-16. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.